NCT04183166TG4050Mayo ClinicHNSCCSouth Central - Oxford
…Background In the phase I trial TG4050.02 ( NCT04183166) evaluating TG4050 in resected, locally advanced HNSCC patients…
5,089articles mentioning funders
9,137funder mentions
3,238distinct funders extracted
0%of mentions human-reviewed
All extracted funders
Showing 1,441–1,500 of 3,238, ordered by supporting articles. Choose a funder to see its evidence.
Hartwell Foundation1Hatzola1Health Canada Clinical Trials1Health Care Accreditation Council1Health Education England1Health Human Research Ethics Committee1Health Innovation Network1Health Insurance Fund1Health Research Ethics Committee1Health Research and Development Information Network1Health Sciences Research Ethics Board1Health Services Cost Review Commission1Health Services Safety Investigation Body1Health Services Safety Investigations Body1Health and Care Research Wales1Health and Disability Ethics Committees1Health and Safety Executive1Healthcare Innovation Consortium1Healthcare Management Information Consortium1Healthier Workforce Center of the Midwest1Healthwatch Essex1Healthy Caribbean Coalition1Hearst Foundation1Heart and Stroke Foundation of Barbados1Helicopter Emergency Medical Services1Hellenic Foundation for Research and Innovation1Helpforce1Heuron Co., Ltd1Highly Specialised Congenital Myopathy Service1Home Office1Hopes and Smiles For Children Foundation1Horizon Europe Framework Programme1Horizon Europe MSCA1Horizon Europe Research and Innovation Programme1Horizon20201Hormozgan University of Medical School Research Ethics Board1Hospice Medicines Management Group1Hospice UK/NHS England1Hospital Admission Risk Program1Hospital trusts1House of Commons1House of Lords Public Services Committee1Human Research Protection Office1Human Research Protection Program1Human Tissue Authority1Humanitarian Device Exemption1Hunter New England Human Ethics Committee1Hunter New England Human Research Ethics Committee1Hunter New England Research Ethics Committee1I-25PJ10551IACUC Committee1IAEA1IAF-PP T-MoVac Programme1IBM1ICBP1ICTRP Registry Network1ICoMICS1ID TJ-IRB202412051-11IDA1IDA211
Articles mentioning funders
5,089 articles · page 330 of 425NCT04162015nivolumabDiffuse pleural mesotheliomapemetrexedcisplatincarboplatinplatinumP/D
…exed prior to P/D (2 cycles) for patients with resectable DPM ( NCT04162015).Methods To comprehensively assess tumor and immune microenviro…
Bristol-Myers Squibbneoadjuvant immunotherapynivolumabEGFR-mutant NSCLCchemotherapyCTONG1104
…and families involved in this study. This work was supported by Bristol-Myers Squibb, Guangdong Provincial Key Lab of Translational Medicine in Lung…
Foundation for the National Institutes of Health, Inc.CAN-2409docetaxelNSCLCsacituzumab govitecanvalacyclovir
…oject was made possible through funding support provided to the Foundation for the National Institutes of Health, Inc. (FNIH) by: AbbVie Inc., Amgen Inc., Boehringer-Ingelheim Pharma…
AstraZenecadurvalumabcapivasertibDurvaolaparibOlaCaprelapse/refractory solid cancers
…ing macrophages and stromal cells are underway.Acknowledgements AstraZeneca’s support is gratefully acknowledgedTrial Registration NCT03772…
Astellas Pharma Inc.ASP1012la/m solid tumorsadvanced solid tumorsOxford PharmaGenesis Inc.
…uding 3×10 9 pfu/dose.Acknowledgements This study was funded by Astellas Pharma Inc. Medical writing support, conducted in accordance with Good Publ…
IRB00115160cemiplimabEmory Universitymetastatic cutaneous squamous cell carcinoma (CSCC)
…proval The study was approved by the Emory IRB (approval number IRB00115160) and participants gave informed consent to take part in this st…
FDAMitazalimabmFOLFIRINOX
… Journal for ImmunoTherapy of Cancer 2024;12(Suppl 2):A677–A678.FDA. Optimizing the dose of human prescription drugs and biological…
FDAEVOLVE104EIU-104101urothelial carcinomasquamous cell carcinomasCohort BCohort AEVOLVE TCEstransitional cell carcinomas of the urinary tractlocally advanced or metastatic solid tumors
…g.Ethics Approval Study EIU-104101 is currently under review by FDA and will only begin enrollment upon clearance from relevant hea…
American Surgical Association Research AwardAppendiceal cancerMD Anderson Cancer CenterBarnes-Jewish HospitalpaclitaxelUniversity of Texas MD Anderson Cancer Centercolorectal cancerWashington University Institutional Review Board
…cy.Acknowledgements This work was supported by funding from the American Surgical Association Research Award (Dr. Beth A. Helmink), NIH grant R37AI049653 (Dr. Gwendalyn J. …
PHASE ONE FoundationECOG Performance StatusDana-Farber Cancer InstituteIL-12myeloid leukemiaIL-15IL-18PROCpembrolizumabDana-Farber/Harvard Cancer Center+6 more
…uable. The authors are deeply grateful for funding support from PHASE ONE Foundation and from Pan-Mass Challenge Team Ovarian Cancer.References Disi…
Mount Sinai PPHS IRBHNSCCimmunotherapyMount Sinai Institutional BiorepositoryHead and neck squamous cell carcinoma (HNSCC)
…drivers of immunotherapy resistance among HNSCC.Ethics Approval Mount Sinai PPHS IRB approved STUDY-21-01683…